Technion Israel Institute of Technology

Drug-Free Nanoparticles Could Reshape Future Cancer Therapies

Prof. Assaf Zinger's team at Technion Israel developed drug-free MPsomes, slowing aggressive breast cancer tumors in preclinical models by altering the immune.